Evidence map›Paper›PMID 35139116›Full record

ArticlePLoS neglected tropical diseases2022

A multi-epitope fusion antigen candidate vaccine for Enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model.

Richard M Jones, Hyesuk Seo, Weiping Zhang, David A Sack

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Recent progress in enterotoxigenicInfection and immunity · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Review
  11. Special Issue on EnterotoxigenicMicroorganisms · 2024
    Article
  12. Recent advances in enterotoxin vaccine adjuvants.Current opinion in immunology · 2023
    Review
  13. Article
  14. Article
  15. Evaluation of Multivalent EnterotoxigenicApplied and environmental microbiology · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Richard M JonesJohns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Hyesuk SeoUniversity of Illinois at Urbana-Champaign, Department of Pathobiology, Urbana, Illinois, United States of America.
Weiping ZhangUniversity of Illinois at Urbana-Champaign, Department of Pathobiology, Urbana, Illinois, United States of America.
David A SackJohns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
University of Illinois Urbana-Champaign · USJohns Hopkins University · USUniversity of Washington · US

Funding

A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associateddiarrheaR01AI121067 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ZHANG, WEIPING · 2016 to 2020
$2.0M
NIAID NIH HHS R01 AI121067
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a leading cause of children's and travelers' diarrhea. Developing effective vaccines against this heterologous group has proven difficult due to the varied nature of toxins and adhesins that determine their pathology. A multivalent candidate vaccine was developed using a multi-epitope fusion antigen (MEFA) vaccinology platform and shown to effectively elicit broad protective antibody responses in mice and pigs. However, direct protection against ETEC colonization of the small intestine was not measured in these systems. Colonization of ETEC strains is known to be a determining factor in disease outcomes and is adhesin-dependent. In this study, we developed a non-surgical rabbit colonization model to study immune protection against ETEC colonization in rabbits. We tested the ability for the MEFA-based vaccine adhesin antigen, in combination with dmLT adjuvant, to induce broad immune responses and to protect from ETEC colonization of the rabbit small intestine. Our results indicate that the candidate vaccine MEFA antigen elicits antibodies in rabbits that react to seven adhesins included in its construction and protects against colonization of a challenge strain that consistently colonized naïve rabbits.

Indexed as

AnimalsAntibodies, BacterialAntigens, BacterialDiarrheaDisease Models, AnimalEnterotoxigenic Escherichia coliEpitopesEscherichia coli InfectionsEscherichia coli VaccinesHumansImmunizationIntestine, SmallRabbitsAntibodies, BacterialAntigens, BacterialEpitopesEscherichia coli Vaccines

Identifiers

PMID35139116
PMCPMC8863229
OpenAlexW4210935077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.